Your browser doesn't support javascript.
loading
GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.
Eriksson, Daniel; Røyrvik, Ellen Christine; Aranda-Guillén, Maribel; Berger, Amund Holte; Landegren, Nils; Artaza, Haydee; Hallgren, Åsa; Grytaas, Marianne Aardal; Ström, Sara; Bratland, Eirik; Botusan, Ileana Ruxandra; Oftedal, Bergithe Eikeland; Breivik, Lars; Vaudel, Marc; Helgeland, Øyvind; Falorni, Alberto; Jørgensen, Anders Palmstrøm; Hulting, Anna-Lena; Svartberg, Johan; Ekwall, Olov; Fougner, Kristian Johan; Wahlberg, Jeanette; Nedrebø, Bjørn Gunnar; Dahlqvist, Per; Knappskog, Per Morten; Wolff, Anette Susanne Bøe; Bensing, Sophie; Johansson, Stefan; Kämpe, Olle; Husebye, Eystein Sverre.
Affiliation
  • Eriksson D; Centre for Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
  • Røyrvik EC; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
  • Aranda-Guillén M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Berger AH; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Landegren N; K.G. Jebsen Center for Autoimmune Diseases, University of Bergen, Bergen, Norway.
  • Artaza H; Centre for Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
  • Hallgren Å; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Grytaas MA; K.G. Jebsen Center for Autoimmune Diseases, University of Bergen, Bergen, Norway.
  • Ström S; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Bratland E; Centre for Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
  • Botusan IR; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Oftedal BE; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Breivik L; K.G. Jebsen Center for Autoimmune Diseases, University of Bergen, Bergen, Norway.
  • Vaudel M; Centre for Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
  • Helgeland Ø; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Falorni A; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Jørgensen AP; Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden.
  • Hulting AL; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Svartberg J; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Ekwall O; K.G. Jebsen Center for Autoimmune Diseases, University of Bergen, Bergen, Norway.
  • Fougner KJ; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Wahlberg J; Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden.
  • Nedrebø BG; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Dahlqvist P; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Knappskog PM; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Wolff ASB; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Bensing S; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Johansson S; Department of Genetics and Bioinformatics, Domain of Health Data and Digitalisation, Institute of Public Health, Oslo, Norway.
  • Kämpe O; Department of Medicine, University of Perugia, Perugia, Italy.
  • Husebye ES; Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway.
Nat Commun ; 12(1): 959, 2021 02 11.
Article de En | MEDLINE | ID: mdl-33574239
ABSTRACT
Autoimmune Addison's disease (AAD) is characterized by the autoimmune destruction of the adrenal cortex. Low prevalence and complex inheritance have long hindered successful genetic studies. We here report the first genome-wide association study on AAD, which identifies nine independent risk loci (P < 5 × 10-8). In addition to loci implicated in lymphocyte function and development shared with other autoimmune diseases such as HLA, BACH2, PTPN22 and CTLA4, we associate two protein-coding alterations in Autoimmune Regulator (AIRE) with AAD. The strongest, p.R471C (rs74203920, OR = 3.4 (2.7-4.3), P = 9.0 × 10-25) introduces an additional cysteine residue in the zinc-finger motif of the second PHD domain of the AIRE protein. This unbiased elucidation of the genetic contribution to development of AAD points to the importance of central immunological tolerance, and explains 35-41% of heritability (h2).
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d&apos;Addison / Étude d&apos;association pangénomique Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2021 Type de document: Article Pays d'affiliation: Suède

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d&apos;Addison / Étude d&apos;association pangénomique Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2021 Type de document: Article Pays d'affiliation: Suède